bluebird bio, Inc.
BLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $2 | $11 | $14 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $2 | $11 | $14 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 184.1% | 720% | -1.8% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6.6% | -13.7% | -180.2% | -961.1% |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | -187.1% | -566.7% | -5,992.7% | -15,208.2% |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -287.2% | -718.4% | -6,403.7% | -22,375.2% |
| EPS Diluted | -24.84 | -2.97 | -3.39 | -8.16 |
| % Growth | -736.4% | 12.4% | 58.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$1 |